Jim Simons’s Bio-Rad Laboratories Class B BIO.B Stock Holding History

Jim Simons’s Portfolio BIO.B Stock Details BIO.B Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,900	Closed	-$675K	–	3743
2023 Q3	$675K	Hold	1,900	–	–	﹤0.01%	2562
2023 Q2	$705K	Hold	1,900	–	–	﹤0.01%	2690
2023 Q1	$882K	Hold	1,900	–	–	﹤0.01%	2554
2022 Q4	$384K	Sell	1,900 -200	-10%	-$81.7K	﹤0.01%	3104
2022 Q3	$879K	Hold	2,100	–	–	﹤0.01%	2573
2022 Q2	$990K	Buy	2,100 +100	+5%	+$53.4K	﹤0.01%	2729
2022 Q1	$1.18M	Sell	2,000 -200	-9%	-$125K	﹤0.01%	2625
2021 Q4	$1.59M	Sell	2,200 -100	-4%	-$74.6K	﹤0.01%	2329
2021 Q3	$1.75M	Hold	2,300	–	–	﹤0.01%	2195
2021 Q2	$1.47M	Hold	2,300	–	–	﹤0.01%	2451
2021 Q1	$1.33M	Sell	2,300 -600	-21%	-$357K	﹤0.01%	2471
2020 Q4	$1.67M	Sell	2,900 -100	-3%	-$57.2K	﹤0.01%	2230
2020 Q3	$1.52M	Buy	3,000 +100	+3%	+$51.2K	﹤0.01%	2280
2020 Q2	$1.27M	Buy	2,900 +900	+45%	+$381K	﹤0.01%	2430
2020 Q1	$703K	Buy	2,000 +700	+54%	+$258K	﹤0.01%	2598
2019 Q4	$480K	Buy	1,300 +100	+8%	+$35.3K	﹤0.01%	2919
2019 Q3	$409K	Buy	1,200 +100	+9%	+$33K	﹤0.01%	2937
2019 Q2	$337K	Hold	1,100	–	–	﹤0.01%	3137
2019 Q1	$333K	Hold	1,100	–	–	﹤0.01%	3058
2018 Q4	$253K	Hold	1,100	–	–	﹤0.01%	3079
2018 Q3	$327K	Hold	1,100	–	–	﹤0.01%	2990
2018 Q2	$314K	Hold	1,100	–	–	﹤0.01%	2952
2018 Q1	$276K	Hold	1,100	–	–	﹤0.01%	3103
2017 Q4	$262K	Hold	1,100	–	–	﹤0.01%	3061
2017 Q3	$251K	Hold	1,100	–	–	﹤0.01%	2946
2017 Q2	$248K	Hold	1,100	–	–	﹤0.01%	2948
2017 Q1	$220K	Hold	1,100	–	–	﹤0.01%	2979
2016 Q4	$201K	Buy	+1,100	New	+$189K	﹤0.01%	3002

Other funds holding BIO.B

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BSW

Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

JFA

JNBA Financial Advisors Bloomington, Minnesota $1.32B AUM 24.95% 1-Year Est. Return

Jim Simons's BIO.B Position: Q4 2023 in Review

Jim Simons sold out of Bio-Rad Laboratories Class B (BIO.B) in Q4 2023, closing a stake of 1,900 shares — an estimated $675K sold.

Jim Simons first reported a position in BIO.B in Q4 2016 and held it in 28 quarters. The position peaked at $1.75M in Q3 2021. 6 funds tracked by Wall St. Rank hold BIO.B as of Q4 2023.

Jim Simons reported no remaining Bio-Rad Laboratories Class B position as of Q4 2023 after selling out during the quarter.
Jim Simons sold 1,900 Bio-Rad Laboratories Class B shares in Q4 2023, an estimated $675K.
Jim Simons first reported a position in Bio-Rad Laboratories Class B in Q4 2016 and held it in 28 quarters.
Jim Simons's Bio-Rad Laboratories Class B position peaked at $1.75M in Q3 2021.
6 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class B as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.